Pam Connealy

Salesforce Mimecast Outlook Google Tag Manager reCAPTCHA Mobile Friendly Greenhouse.io New Relic Google Font API WordPress.org Nginx Render Remote

immunooncology & oncology biotechnology: pharmaceutical preparations health care biotechnology research pyxis oncology cancer therapeutics antibody-drug conjugates adcs immuno-oncology tumor targeting clinical assets fda approval pipeline biopharmaceuticals monoclonal antibodies immune checkpoints therapeutic window next-generation adc payload design linker technology tumor microenvironment cell-permeable cytotoxic agents preclinical research clinical trials phase 1 phase 2 biotech innovation patient outcomes malignancies tumor response immune suppression cancer treatment antibody discovery platform apximab fact platform fda orphan drug designation cancer-killing agents anti-siglec-15 biomarker analysis immune regulatory mechanisms pd-1 inhibitors cytotoxic activity patient engagement scientific publications clinical development portfolio management patient-centered biotechnology pharmaceutical development molecular targeting health wellness & fitness hospital & health care